BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250929T140000
DTEND;TZID=Europe/London:20250929T150000
DTSTAMP:20260829T213804
CREATED:20250827T141747Z
LAST-MODIFIED:20250829T120221Z
UID:100115260-1759154400-1759158000@www.pathologynews.com
SUMMARY:Evaluation of HER2-Low and Ultralow Status of Advanced Breast Carcinomas
DESCRIPTION:0000Days00Hrs00Min00SecJoin this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology\, Sahlgrenska University Hospital\, Gothenburg\, Sweden) will present findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies. \nThe aim of the study was to: \n\ncompare the outcome of HER2 scoring using conventional microscopy\, digital pathology\, and AI.\nassess changes in HER2-low status in core biopsies\, matching operation specimens\, and their distant metastases.\n\nRegister for the webinar to learn more about the findings and how AI can help determine a more accurate HER2-low status\, providing an exact percentage of each HER2 score within seconds with high accuracy. \nWho should join?\n\nPathologists involved in biomarker testing\nOncologists relying on HER2-low status in treatment decisions\nAnyone involved in breast cancer diagnostics or therapeutic decision-making\nAnyone interested in using or developing AI models for image analysis in digital pathology\n\nRegister NowSpeakersAnikó Kovács\, MD\, PhD\nAssociate Professor\, Pathologist\, and Lecturer\nSahlgrenska University Hospital \n\nHas worked in research in Sweden for the past 23 years\nBreast cancer research at the Leicester University in the UK\nResearch background also in Japan (Kitasato University) and Hungary\n\nRute Pedrosa\, PhD\nSenior Field Application Scientist\nAiforia Technologies \n\nHas worked at Aiforia for 2.5 years\nPhD at Erasmus University Rotterdam\, focusing on the pathogenesis of brain metastatic disease
URL:https://www.pathologynews.com/event/evaluation-of-her2-low-and-ultralow-status-of-advanced-breast-carcinomas/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/aiforia-her2-low-webinar-pathologynews.jpg
END:VEVENT
END:VCALENDAR